Jiawei Xu, Yuxin Pan, Rebecca Mary Peter, Pochung Jordan Chou, Parv Dushyant Dave, Ahmad Shanner, Md Shahid Sarwar, Lugui Brunetti, James E Simon, Ah-Ng Tony Kong
{"title":"酸樱桃浓缩汁抗氧化和抗炎潜能的表观遗传和代谢途径探讨。","authors":"Jiawei Xu, Yuxin Pan, Rebecca Mary Peter, Pochung Jordan Chou, Parv Dushyant Dave, Ahmad Shanner, Md Shahid Sarwar, Lugui Brunetti, James E Simon, Ah-Ng Tony Kong","doi":"10.1007/s40495-025-00422-1","DOIUrl":null,"url":null,"abstract":"<p><p>Tart cherry (TC; <i>Prunus cerasus</i>) has high antioxidant and anti-inflammatory potentials due to its rich bioactive components like anthocyanins, polyphenols, vitamins, beta-carotene, ellagic acid, and chlorogenic acid. Oxidative damage and inflammation are underlying reasons to chronic disease pathogenesis. Oxidative stress usually caused by the imbalance between antioxidants and pro-oxidants. Additionally, a chronic inflammatory state is typically modulated by oxidative stress. Inflammation plays a critical role in chronic health conditions, such as cardiovascular diseases, hypertension, insulin resistance, arthritis and cancer. Numerous studies indicate that there is a strong relationship between TC and the inhibition of inflammation and oxidative damage by regulating different epigenetic and metabolic pathways. In this review, the recent developments of TC components and their metabolites on inflammatory and oxidative damages will be discussed, and the challenges and limitations to better support future research, including clinical trials to confirm these findings.</p><p><strong>Graphical abstract: </strong></p>","PeriodicalId":11139,"journal":{"name":"Current Pharmacology Reports","volume":"11 1","pages":"43"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12296803/pdf/","citationCount":"0","resultStr":"{\"title\":\"Exploring the Epigenetic and Metabolic Pathways for Antioxidant and Anti-Inflammatory Potentials of Tart Cherry Juice Concentrate.\",\"authors\":\"Jiawei Xu, Yuxin Pan, Rebecca Mary Peter, Pochung Jordan Chou, Parv Dushyant Dave, Ahmad Shanner, Md Shahid Sarwar, Lugui Brunetti, James E Simon, Ah-Ng Tony Kong\",\"doi\":\"10.1007/s40495-025-00422-1\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Tart cherry (TC; <i>Prunus cerasus</i>) has high antioxidant and anti-inflammatory potentials due to its rich bioactive components like anthocyanins, polyphenols, vitamins, beta-carotene, ellagic acid, and chlorogenic acid. Oxidative damage and inflammation are underlying reasons to chronic disease pathogenesis. Oxidative stress usually caused by the imbalance between antioxidants and pro-oxidants. Additionally, a chronic inflammatory state is typically modulated by oxidative stress. Inflammation plays a critical role in chronic health conditions, such as cardiovascular diseases, hypertension, insulin resistance, arthritis and cancer. Numerous studies indicate that there is a strong relationship between TC and the inhibition of inflammation and oxidative damage by regulating different epigenetic and metabolic pathways. In this review, the recent developments of TC components and their metabolites on inflammatory and oxidative damages will be discussed, and the challenges and limitations to better support future research, including clinical trials to confirm these findings.</p><p><strong>Graphical abstract: </strong></p>\",\"PeriodicalId\":11139,\"journal\":{\"name\":\"Current Pharmacology Reports\",\"volume\":\"11 1\",\"pages\":\"43\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12296803/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current Pharmacology Reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/s40495-025-00422-1\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/7/26 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"Biochemistry, Genetics and Molecular Biology\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Pharmacology Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s40495-025-00422-1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/7/26 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
Exploring the Epigenetic and Metabolic Pathways for Antioxidant and Anti-Inflammatory Potentials of Tart Cherry Juice Concentrate.
Tart cherry (TC; Prunus cerasus) has high antioxidant and anti-inflammatory potentials due to its rich bioactive components like anthocyanins, polyphenols, vitamins, beta-carotene, ellagic acid, and chlorogenic acid. Oxidative damage and inflammation are underlying reasons to chronic disease pathogenesis. Oxidative stress usually caused by the imbalance between antioxidants and pro-oxidants. Additionally, a chronic inflammatory state is typically modulated by oxidative stress. Inflammation plays a critical role in chronic health conditions, such as cardiovascular diseases, hypertension, insulin resistance, arthritis and cancer. Numerous studies indicate that there is a strong relationship between TC and the inhibition of inflammation and oxidative damage by regulating different epigenetic and metabolic pathways. In this review, the recent developments of TC components and their metabolites on inflammatory and oxidative damages will be discussed, and the challenges and limitations to better support future research, including clinical trials to confirm these findings.
期刊介绍：
Current Pharmacology Reports will: publish cutting-edge reviews on subjects pertinent to all aspects of pharmacology, including drug discovery and development.provide incisive, insightful, and balanced contributions from international leading experts.interest a wide readership of basic scientists and translational investigators in academia and in industry. The Current Pharmacology Reports journal accomplishes its goal by appointing international authorities to serve as Section Editors in key subject areas, such as: epigenetics and epigenomics, chemoinformatics and rational drug design and target discovery, drug delivery and biomaterial, pharmacogenomics and molecular targets and biomarkers, chemical/drug/molecular toxicology, absorption, distribution, metabolism and elimination (ADME), pharmacokinetics (PK) and pharmacodynamics (PD), Modeling & Simulation (M&S) and pharmacometrics, and other related topics in pharmacology including neurology/central nervous system (CNS), cardiovascular, metabolic diseases, cancer, among others. Section Editors for Current Pharmacology Reports select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. An Editorial Board of internationally diverse members suggests topics of special interest to their country/region and ensures that topics are current and include emerging research. Commentaries from well-known figures in the field are also provided. This journal publishes on a bi-monthly schedule.Please submit here: https://www.editorialmanager.com/phar/default.aspx
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
